Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trial

Abstract

The present study provides novel evidence concerning long-term MACE and haemorrhage following aspirin use in initially healthy older adults. The finding of no long-term MACE benefit needs to be considered in clinical decision-making if aspirin is being considered for use in this context.